Contents
On this page
- Quick answer
- Overview
- Case Study 1: Turning a “Mini Systematic Review” into a Proper Scoping Review
- Case Study 2: Fixing PRISMA-ScR Gaps After Peer Review
- Case Study 3: Registering Two Protocols Under Deadline Pressure
- Case Study 4: Evidence Reviews for an AWMF S3 Guideline Update
- Lessons Across the Case Studies
- Conclusion
- Frequently asked questions
- Sources
InsightsCase Study
Case study
Scoping Review and Protocol Case Studies: Four Illustrative Scenarios
Four illustrative scenarios: a mini systematic review rebuilt as a scoping review, PRISMA-ScR gaps fixed, two protocols registered and evidence reviews for an S3 guideline.
- Scoping review
- Case study
- Protocol registration
- Scenarios
- 4, illustrative
- Scoping reporting
- PRISMA-ScR (20 + 2 optional items)
- Scoping registries
- OSF, INPLASY or published protocol
- Guidelines
- AWMF S3, GRADE optional
At a glanceCase Study
Explore scoping review servicesDiscuss your project
Quick answer
- Use a scoping review to map evidence and a systematic review to answer a focused question; then pick the protocol guidance, registry and reporting checklist that match.
- PROSPERO does not accept scoping reviews; register them on OSF Registries or INPLASY, or publish the protocol.
- Report registration honestly: a record created after screening is retrospective.
Overview
Each scoping review case study below follows the same pattern: the problem, why it matters, what was changed and what the change cannot do. The four scenarios cover choosing between a scoping and a systematic review, reporting to PRISMA-ScR, registering protocols for a mixed-method project, and evidence reviews for a German AWMF S3 guideline.
The thread running through all four is fit: the review type must match the question, and the reporting guideline and registry must match the review type1. Scoping reviews map the extent and nature of evidence and are reported with PRISMA-ScR2; systematic reviews answer focused questions and are reported with PRISMA 20203.
All four cases are illustrative scenarios: composites of typical problems, not accounts of real clients or real outcomes. For grey literature, search reporting and joint clinical assessment scenarios, see the companion systematic review case studies.
Table 1. The four illustrative scenarios at a glance
| Case | Problem | Main fix | Guidance used |
|---|---|---|---|
| 1 | Broad mapping question run as a "mini systematic review" | Reframe with PCC; JBI scoping methods; charting form | JBI guidance, PRISMA-ScR |
| 2 | PRISMA-ScR gaps raised in peer review | Correct registration statement; full search; items 12 and 16 | PRISMA-ScR |
| 3 | Systematic and scoping components on a tight timeline | Two protocols, two registries, cross-referenced | PRISMA-P, JBI protocol guidance |
| 4 | Many key questions for an S3 guideline update | Full and rapid reviews, documented and agreed in advance | AWMF Regelwerk, GRADE, Cochrane rapid review guidance |
Case Study 1: Turning a “Mini Systematic Review” into a Proper Scoping Review
Illustrative scenario. A composite based on typical challenges; it does not describe an identifiable client, project or result.
| Profile | Detail |
|---|---|
| Scenario | Nursing research group planning its first evidence synthesis |
| Typical requester | Academic team, often in nursing or allied health |
| Topic | Digital health in older adults |
| Service focus | Method redesign, protocol and data charting |
Challenge. The team had a broad question about digital health in older adults, but its draft protocol applied PICO, a risk of bias tool and a meta-analysis plan to sources ranging from trials to qualitative studies and policy documents.
Why it matters. When the aim is to map what evidence exists, identify gaps or clarify concepts, a scoping review is the appropriate design; forcing systematic review methods onto that aim produces a review that answers neither question well1.
Approach.
- Reframed the question with the Population, Concept and Context (PCC) mnemonic used in JBI scoping review guidance4.
- Rewrote the protocol following JBI guidance for scoping review protocols5, including eligible types of evidence source, languages and dates.
- Registered the protocol on OSF Registries using the Generalized Systematic Review Registration form before screening began6. PROSPERO was not an option because it does not accept scoping reviews7.
- Replaced the extraction and risk of bias forms with a charting form limited to items tied to the review questions, piloted by two reviewers8.
- Planned a tabular evidence map of intervention types against reported outcomes, with a narrative summary8.
Illustrative outcome. The review was conducted and reported as a scoping review, with a prospectively registered protocol and a method that matched its aim. See the step-by-step guide how to write a scoping review and our scoping review service.
Limitation. A scoping review describes the volume and nature of the evidence; it cannot say whether digital interventions are effective. If that question matters, a later systematic review is needed1.
Case Study 2: Fixing PRISMA-ScR Gaps After Peer Review
Illustrative scenario. A composite based on typical challenges; it does not describe an identifiable client, project or result.
| Profile | Detail |
|---|---|
| Scenario | Scoping review returned with major revisions |
| Typical requester | Public health research team |
| Topic | Community health interventions |
| Service focus | PRISMA-ScR reporting revision |
Challenge. Peer reviewers noted that the manuscript claimed PROSPERO registration (the authors had cited an earlier PROSPERO submission that had been rejected as out of scope), gave search terms rather than a full search strategy, and did not say whether sources of evidence had been critically appraised.
Why it matters. Readers and editors judge a scoping review partly on whether its methods can be checked and reproduced; PRISMA-ScR sets out the minimum information needed to do that2.
Approach.
- Registration statement (item 5). PROSPERO does not register scoping reviews7, so the claim had to be corrected. Because the team had registered the protocol on OSF before screening, the statement was changed to cite that OSF record, its DOI and its registration date. Had no record existed before screening, the honest statement would have been that the review was not prospectively registered; any registration created afterwards would need to be labelled retrospective, with its date.
- Search strategy (item 8). Added the full electronic search strategy for at least one database, including limits, as a supplementary file2.
- Critical appraisal (items 12 and 16). These items are optional in PRISMA-ScR; the methods now state explicitly that appraisal was not performed, consistent with JBI guidance for scoping reviews24.
- Selection of sources (item 14). Reconciled numbers screened, assessed and included, with reasons for exclusion at each stage, and presented them in a flow diagram, which PRISMA-ScR recommends ("ideally") rather than requires2.
Illustrative outcome. The response to reviewers addressed each PRISMA-ScR comment point by point, with a completed checklist giving page numbers. The editorial decision rested, as always, with the journal. For every item explained, see PRISMA-ScR checklist explained item by item; for a pre-submission check, see our reporting checklist review.
Limitation. Better reporting cannot repair a method that was never carried out. If no protocol existed before screening, the manuscript should say so rather than present a later record as prospective registration.
Planning or revising a scoping review?
Pubrica’s review team supports PCC question framing, JBI-based protocols, OSF or INPLASY registration, searching, charting and PRISMA-ScR reporting. Authors keep ownership of and accountability for the review, and no provider can guarantee acceptance or set a journal’s or registry’s timeline.
Case Study 3: Registering Two Protocols Under Deadline Pressure
Illustrative scenario. A composite based on typical challenges; it does not describe an identifiable client, project or result.
| Profile | Detail |
|---|---|
| Scenario | Doctoral project with a systematic review and a scoping review |
| Typical requester | Doctoral researcher and supervisors |
| Topic | Exercise therapy for a chronic condition |
| Service focus | Protocol writing and PROSPERO/OSF registration |
Challenge. A thesis timeline left little time before screening had to start, and the planned review combined a focused effectiveness question with a broad mapping question.
Why it matters. Registering a protocol before the review begins makes changes to the planned methods visible and helps reduce duplication and selective reporting910.
Approach.
- Split the work into two linked reviews: a systematic review of effectiveness and a scoping review of the wider evidence.
- Wrote the systematic review protocol to PRISMA-P11 and the scoping review protocol to JBI scoping protocol guidance5.
- Registered the systematic review on PROSPERO, which accepts systematic reviews with at least one health-related outcome7. PROSPERO’s published rules accepted a review only if data extraction had not been completed9; check PROSPERO’s current eligibility guidance before registering. PROSPERO was relaunched in March 2025 with more automated processing, so allow time for checks rather than assuming a fixed turnaround12.
- Registered the scoping review on OSF Registries using the Generalized Systematic Review Registration form6. OSF records are time-stamped, and later changes are filed as formal updates with a justification13.
- Kept an amendment log for both records so that any change could be dated and explained.
How the two registrations are reported. Each review reports its own record: the systematic review gives the PROSPERO name and registration number under PRISMA 2020 item 24a, with protocol access and amendments under items 24b and 24c3; the scoping review gives the OSF registration details under PRISMA-ScR item 52. Each record and each manuscript cross-references the other so readers can see the two reviews are linked. Registry options are compared in PROSPERO vs OSF vs INPLASY and the PROSPERO registration guide.
Illustrative outcome. Both protocols were publicly registered before screening, and the thesis chapters cited each record. Support of this kind sits within our systematic review service; the doctoral researcher remained the registrant and author of both records.
Limitation. Registration timing depends partly on the registry: processing times vary and cannot be guaranteed, so registration should be planned well ahead of screening rather than left until the deadline.
Case Study 4: Evidence Reviews for an AWMF S3 Guideline Update
Illustrative scenario. A composite based on typical challenges; it does not describe an identifiable client, project or result.
| Profile | Detail |
|---|---|
| Scenario | Update of an S3 guideline with a fixed consensus conference date |
| Typical requester | A guideline development group of a German medical society |
| Topic | A clinical guideline topic |
| Service focus | Systematic and rapid evidence reviews to AWMF S3 rules |
Challenge. The guideline group had a set of key questions that needed evidence before a scheduled consensus conference; a subset needed urgent updating because new studies had appeared since the last version.
Why it matters. Under the AWMF rules, S3 guidelines combine systematic evidence retrieval and appraisal with structured consensus, and the methods are documented in the guideline report (Leitlinienreport); weak or undocumented evidence work undermines the recommendations built on it14.
Approach.
- Structured each key question with PICO or an adapted framework where PICO did not fit, such as for diagnostic or prognostic questions.
- Ran full systematic reviews for most questions. For the urgent subset, the group agreed in advance, with its AWMF guideline advisor, to use rapid reviews and to document every simplification, following Cochrane rapid review guidance1516.
- Rated the certainty of evidence with GRADE, which the guideline group had chosen as its method; AWMF permits GRADE but does not mandate it1714.
- Delivered evidence tables and GRADE evidence profiles in the format needed for the guideline report.
Illustrative outcome. The group received evidence summaries for every key question before the consensus conference, with methods, including rapid review shortcuts, documented for the guideline report. For the rules in detail, see AWMF S3 guidelines and evidence reviews; for urgent questions, see our rapid review service.
Limitation. Rapid reviews trade some thoroughness for speed, so their findings carry more uncertainty than a full systematic review; that trade-off should be stated in the guideline report16. Recommendations remain the decision of the guideline group in its consensus process.
Lessons Across the Case Studies
The same principles recur in every scenario:
| Principle | In practice |
|---|---|
| Match method to question | PCC and scoping methods for mapping; PICO for focused effectiveness questions1. |
| Register before screening | Choose the registry by review type: PROSPERO for eligible systematic and rapid reviews; OSF, INPLASY or a published protocol for scoping reviews710. |
| Report registration honestly | Label a record created after screening as retrospective, or state that the review was not registered. |
| Report to the right guideline | PRISMA-ScR for scoping reviews; PRISMA 2020 for systematic reviews; PRISMA-P or JBI guidance for protocols23115. |
| Document shortcuts | State and justify every rapid review simplification16. |
Before you start a review: quick checks
- Is the aim to map evidence (scoping review) or to answer a focused question (systematic review)?
- Is the protocol written to the right guidance: PRISMA-P for a systematic review, JBI protocol guidance for a scoping review?
- Is the chosen registry open to this review type, and is there time to register before screening?
- Does the manuscript state the registry, record number or DOI and registration date, and any amendments?
- Are any rapid review shortcuts agreed with the end users and documented?
- Is the completed reporting checklist ready to submit with page numbers?
Conclusion
Each scoping review case study shows that choosing the right review type, registering the protocol in a suitable registry at the right time and reporting to the matching guideline make a review easier for editors, peer reviewers and guideline groups to assess and trust. None of these steps guarantees a particular decision; they make the evidence and its limits visible.
Pubrica team verdict
In each scenario the fix was the same: match the review type to the question, then the protocol guidance, registry and reporting checklist to the review type.
Frequently asked questions
Sources
Sources were checked on 22 November 2026. Requirements and guidance may change after that date; confirm the current version with the issuing body.
- 1Munn Z, Peters MDJ, Stern C, Tufanaru C, McArthur A, Aromataris E. Systematic review or scoping review? Guidance for authors when choosing between a systematic or scoping review approach. BMC Med Res Methodol. 2018;18(1):143. https://doi.org/10.1186/s12874-018-0611-x
- 2Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-73. https://doi.org/10.7326/M18-0850
- 3Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71
- 4Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evid Synth. 2020;18(10):2119-26. https://doi.org/10.11124/JBIES-20-00167
- 5Peters MDJ, Godfrey C, McInerney P, Khalil H, Larsen P, Marnie C, et al. Best practice guidance and reporting items for the development of scoping review protocols. JBI Evid Synth. 2022;20(4):953-68. https://doi.org/10.11124/JBIES-21-00242
- 6van den Akker OR, Peters GY, Bakker CJ, Carlsson R, Coles NA, Corker KS, et al. Increasing the transparency of systematic reviews: presenting a generalized registration form. Syst Rev. 2023;12(1):170. https://doi.org/10.1186/s13643-023-02281-7
- 7Centre for Reviews and Dissemination. PROSPERO [Internet]. York: University of York [cited 2026 Nov 22]. Available from: https://www.crd.york.ac.uk/prospero/
- 8Pollock D, Peters MDJ, Khalil H, McInerney P, Alexander L, Tricco AC, et al. Recommendations for the extraction, analysis, and presentation of results in scoping reviews. JBI Evid Synth. 2023;21(3):520-32. https://doi.org/10.11124/JBIES-22-00123
- 9Booth A, Clarke M, Dooley G, Ghersi D, Moher D, Petticrew M, et al. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews. Syst Rev. 2012;1:2. https://doi.org/10.1186/2046-4053-1-2
- 10Pieper D, Rombey T. Where to prospectively register a systematic review. Syst Rev. 2022;11(1):8. https://doi.org/10.1186/s13643-021-01877-1
- 11Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1. https://doi.org/10.1186/2046-4053-4-1
- 12Centre for Reviews and Dissemination. A new and improved PROSPERO website has been launched [Internet]. York: University of York; 2025 Mar 7 [cited 2026 Nov 22]. Available from: https://www.york.ac.uk/crd/news/2025/prosperoupdate/
- 13Center for Open Science. Registration and preregistration FAQs [Internet]. Charlottesville (VA): Center for Open Science [cited 2026 Nov 22]. Available from: https://help.osf.io/category/549-registration-and-preregistration-faqs
- 14AWMF Ständige Kommission Leitlinien. AWMF-Regelwerk „Leitlinien“, Version 2.2 [Internet]. Berlin: Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF); 2025 [cited 2026 Nov 22]. Available from: https://www.awmf.org/regelwerk
- 15Garritty C, Gartlehner G, Nussbaumer-Streit B, King VJ, Hamel C, Kamel C, et al. Cochrane Rapid Reviews Methods Group offers evidence-informed guidance to conduct rapid reviews. J Clin Epidemiol. 2021;130:13-22. https://doi.org/10.1016/j.jclinepi.2020.10.007
- 16Garritty C, Hamel C, Trivella M, Gartlehner G, Nussbaumer-Streit B, Devane D, et al. Updated recommendations for the Cochrane rapid review methods guidance for rapid reviews of effectiveness. BMJ. 2024;384:e076335. https://doi.org/10.1136/bmj-2023-076335
- 17Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924-6. https://doi.org/10.1136/bmj.39489.470347.AD
- 18International Committee of Medical Journal Editors. Recommendations for the conduct, reporting, editing, and publication of scholarly work in medical journals [Internet]. ICMJE; updated January 2026 [cited 2026 Nov 22]. Available from: https://www.icmje.org/recommendations/
scoping review case studyscoping reviewPRISMA-ScROSF registrationPROSPEROPRISMA-P
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation, so check its guide if it has one.
Dr. Charlie. (2026, November 22). Scoping Review and Protocol Case Studies: Four Illustrative Scenarios. Pubrica. https://pubrica.com/insights/case-study/review-types-protocols-case-studies/
This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Next steps
Planning or revising a scoping review?
Pubrica’s review team supports PCC question framing, JBI-based protocols, OSF or INPLASY registration, searching, charting and PRISMA-ScR reporting. Authors keep ownership of and accountability for the review, and no provider can guarantee acceptance or set a journal’s or registry’s timeline.
This article is general information for researchers, not legal, regulatory or funding advice. Check the current requirements of your journal, funder, ethics committee or regulator before you act on it.
More in Case Study